Biotest AG Vz Value Stock - Dividend - Research Selection
Fundamental data and company key figures of the share
|Annual reports in|
|Net operating cash flow|
|Free cash flow|
|Liabilities & Shareholders equity|
|Diluted shares outstanding|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Raw Data Source|
Description of the company
The Biotest Group, based in Dreieich, Germany, is an international provider of biological medicines. Currently sold products as well as new developments are obtained both from human blood plasma and produced by biotechnological processes. The main therapeutic areas for the application are hematology, clinical immunology and intensive care medicine. Research and development work is carried out by the Biotest Group in all three therapeutic areas. Biotest covers all essential stages of the value chain, from preclinical and clinical development to global marketing.